Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Agents Med Chem ; 18(5): 693-701, 2018.
Article in English | MEDLINE | ID: mdl-29141562

ABSTRACT

BACKGROUND: Electrochemotherapy is a novel treatment for cutaneous and subcutaneous tumors utilizing the combination of electroporation and chemotherapeutic agents. Since tumors have an increasing incidence nowadays as a result of environmental and genetic factors, electrochemotherapy could be a promising treatment for cancer patients. OBJECTIVE: The aim of this article is to summarize the novel knowledge about the use of electroporation for antitumor treatments and to present a new application of electrochemotherapy with a well-known plant derived antitumor drug betulinic acid. For the review we have searched the databases of scientific and medical research to collect the available publications about the use of electrochemotherapy in the treatment of various types of cancer. METHOD: By the utilization of the available knowledge, we investigated the effect of electroporation on the penetration of a topically applied betulinic acid formulation into the skin by ex vivo Raman spectroscopy on hairless mouse skin. RESULTS: Raman measurements have demonstrated that the penetration depth of betulinic acid can be remarkably ameliorated by the use of electroporation, so this protocol can be a possibility for the treatment of deeper localized cancer nodules. Furthermore, it proved the influence of various treatment times, since they caused different spatial distributions of the drug in the skin. CONCLUSION: The review demonstrates that electrochemotherapy is a promising tool to treat different kinds of tumors with high efficiency and with only a few moderate adverse effects. Moreover, it presents a non-invasive method to enhance the penetration of antitumor agents, which can offer novel prospects for antitumor therapies.


Subject(s)
Antineoplastic Agents/pharmacology , Electroporation , Ointments/pharmacology , Skin Neoplasms/drug therapy , Triterpenes/pharmacology , Animals , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Humans , Ointments/chemistry , Pentacyclic Triterpenes , Skin Neoplasms/pathology , Triterpenes/chemistry , Betulinic Acid
2.
Drug Des Devel Ther ; 10: 1695-701, 2016.
Article in English | MEDLINE | ID: mdl-27274203

ABSTRACT

PURPOSE: Transdermal electroporation has become one of the most promising noninvasive methods for drug administration, with greatly increased transport of macromolecules through the skin. The cecal-contracting effects of repeated transdermal electroporation delivery and intravenous administration of neostigmine were compared in anesthetized rats. METHODS: The cecal contractions were detected with implantable strain gauge sensors, and the plasma levels of neostigmine were followed by high-performance liquid chromatography. RESULTS: Both intravenously and EP-administered neostigmine (0.2-66.7 µg/kg) increased the cecal contractions in a dose-dependent manner. For both the low doses and the highest dose, the neostigmine plasma concentrations were the same after the two modes of administration, while an insignificantly higher level was observed at a dose of 20 µg/kg after intravenous administration as compared with the electroporation route. The contractile responses did not differ significantly after the two administration routes. CONCLUSION: The results suggest that electroporation-delivered neostigmine elicits action equivalent to that observed after intravenous administration as concerning both time and intensity. Electroporation permits the delivery of even lower doses of water-soluble compounds through the skin, which is very promising for clinical practice.


Subject(s)
Drug Delivery Systems/methods , Electroporation , Neostigmine/administration & dosage , Neostigmine/blood , Administration, Cutaneous , Administration, Intravenous , Animals , Dose-Response Relationship, Drug , Gastrointestinal Absorption/drug effects , Muscle Contraction/drug effects , Neostigmine/pharmacology , Rats , Rats, Sprague-Dawley
3.
Biomed Opt Express ; 7(1): 67-78, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26819818

ABSTRACT

The aim of the present work was the optimization of the transdermal delivery of a lyotropic liquid crystal genistein-based formulation (LLC-GEN). LLC was chosen as medium in view of the poor solubility of GEN in water. Membrane diffusion and penetration studies were carried out with a Franz diffusion cell, through a synthetic membrane in vitro, a chick chorioallantoic membrane ex ovo, and ex vivo excised human epidermis. Thereafter, LLC-GEN was combined with electroporation (EP) to enhance the transdermal drug delivery. The synergistic effect of EP was verified by in vivo ATR-FTIR and ex vivo Raman spectroscopy on hairless mouse skin.

4.
Int J Mol Sci ; 16(7): 15425-41, 2015 Jul 08.
Article in English | MEDLINE | ID: mdl-26184156

ABSTRACT

A lamellar lyotropic liquid crystal genistein-based formulation (LLC-Gen) was prepared in order to increase the aqueous solubility of the lipophilic phytocompound genistein. The formulation was applied locally, in a murine model of melanoma, with or without electroporation. The results demonstrated that, when the formulation was applied by electroporation, the tumors appeared later. During the 21 days of the experiment, the LLC-Gen formulation decreased the tumor volume, the amount of melanin and the degree of erythema, but when electroporation was applied, all these parameters indicated a better prognosis even (lower tumor volume, amount of melanin and degree of erythema). Although hematoxylin-eosin (HE) staining confirmed the above events, application of the LLC-Gen formulation by electroporation did not lead to a significant effect in terms of the serum concentrations of the protein S100B and serum neuron specific enolase (NSE), or the tissue expression of the platelet-derived growth factor receptor ß (PDGFRß) antibody.


Subject(s)
Anticarcinogenic Agents/chemistry , Drug Carriers/chemistry , Electroporation/methods , Genistein/chemistry , Liquid Crystals/chemistry , Animals , Anticarcinogenic Agents/administration & dosage , Cell Line, Tumor , Chemistry, Pharmaceutical , Female , Genistein/administration & dosage , Immunohistochemistry , Melanoma/drug therapy , Melanoma/metabolism , Melanoma/pathology , Mice , Mice, Inbred C57BL , Phosphopyruvate Hydratase/blood , Receptor, Platelet-Derived Growth Factor beta/metabolism , Rheology , S100 Calcium Binding Protein beta Subunit/blood , Skin/metabolism , Skin/pathology , Transplantation, Homologous , Triazines/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...